Quality is Key
Emery Pharma’s Quality System ensures the quality, safety, and performance requirements for our Clients.
A dedicated Quality Assurance department implements all planned and systematic activities within the quality system. We produce high-quality, actionable data, to strengthen your regulatory package.
Stay in the Know
Emery Pharma scientists write about the work they have done and how they have helped companies like yours. Check out the full list of blogs here.
An Overview of Nitrosated Drug Substance Related Impurities (NDSRIs)
Nitrosamines in Drug Substance (DS) In 2018 health authorities became aware of the nitrosamine N-nitrosodimethylamine (NDMA) in valsartan drug substance. The investigations expanded, NDMA and other potent nitrosamines were found…
The Critical Role of Bioanalytical Platform Selection: Ligand-Binding Assays vs Mass Spectrometry
The selection of a bioanalytical platform is critical because it directly influences the accuracy, sensitivity, and specificity of the data generated, which in turn guides decision-making in drug development. A…
Countdown to Compliance: The August 2025 Deadline for NDSRI Testing Looms Over Pharmaceutical Industry
As the pharmaceutical industry approaches the crucial deadline of August 2025, manufacturers of both currently marketed and newly approved drug products are under increasing pressure to evaluate and control the…